Has the prevalence, clinical presentation and social functioning of schizophrenia changed over the last 25years? Nithsdale schizophrenia survey revisited

Schizophrenia Research

Volumn 146, Issue 1-3, 2013, Pages 349-356

  Shivashankar, Somashekara ^a   Telfer, Susan ^a   Arunagiriraj, Jeyarani ^b   McKinnon, Matthew ^a   Jauhar, Sameer ^c   Krishnadas, Rajeev ^d   McCreadie, Robin ^a  

^a Crichton Royal Hospital   (United Kingdom)

^b Gillbrae Medical Practice   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Antipsychotics; Outcome; Prevalence; Psychopathology; Schizophrenia; Social adjustment

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; LAMOTRIGINE; LITHIUM SALT; NEUROLEPTIC AGENT; VALPROIC ACID;

ADULT; AKATHISIA; ARTICLE; AUTONOMIC DYSFUNCTION; BRADYKINESIA; CLINICAL FEATURE; EMPLOYMENT STATUS; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MUSCLE RIGIDITY; NEGATIVE SYNDROME; OUTCOME ASSESSMENT; PARKINSONISM; POSITIVE SYNDROME; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SOCIAL ADAPTATION; SOCIAL INTERACTION; SUBSTANCE ABUSE; TARDIVE DYSKINESIA; TREMOR; TREND STUDY; UNITED KINGDOM;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; FEMALE; HEALTH SURVEYS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCOTLAND; SELF CONCEPT; SOCIAL ADJUSTMENT; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 84875916451     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.02.006     Document Type: Article

References (45)

1. Allardyce J., Boydell J., Van Os J., Morrison G., Castle D., Murray R.M., McCreadie R.G. Comparison of the incidence of schizophrenia in rural Dumfries and Galloway and urban Camberwell. Br. J. Psychiatry 2001, 179:335-339.
2. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 1995, 57(1):289-300.
3. Buckley P.F., Stahl S.M. Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul-de-sac?. Acta Psychiatr. Scand. 2007, 115(2):93-100.
4. Cantwell R. Substance use and schizophrenia: effects on symptoms, social functioning and service use. Br. J. Psychiatry 2003, 182:324-329.
5. Correll C., Schenk E. Tardive dyskinesia and new antipsychotics. Curr. Opin. Psychiatry 2008, 21:151-156.
6. Dixon L.B., Dickerson F., Bellack A.S., Bennett M., Dickinson D., Goldberg R.W., Lehman A., Tenhula W.N., Calmes C., Pasillas R.M., Peer J., Kreyenbuhl J. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr. Bull. 2009, 36(1):48-70.
7. Great Britain. Dept. of H. National Service Framework for Mental Health: Modern Standards and Service Models 1999, Department of Health, Great Britain.
8. Great Britain. Dept. of H., Social S. Care in the Community: A Consultative Document on Moving Resources for Care in England 1981, Department of Health and Social Security, London, (Alexander Fleming House, Elephant and Castle, SE1 6BY).
9. ISD Drug Misuse Statistics Scotland 2011. Information Services Division 2012, I. Scotland (Ed.).
10. Jansson L.B., Parnas J. Competing definitions of schizophrenia: what can be learned from polydiagnostic studies?. Schizophr. Bull. 2007, 33(5):1178-1200.
11. Jansson L., Handest P., Nielsen J., Saebye D., Parnas J. Exploring boundaries of schizophrenia: a comparison of ICD-10 with other diagnostic systems in first-admitted patients. World Psychiatry 2002, 1(2):109-114.
12. Jobe T., Harrow M. Long-term outcome of patients with schizophrenia: a review. Can. J. Psychiatry 2005, 50(14):892-900.
13. Kendler K.S., Munoz R.A., Murphy G. The development of the Feighner criteria: a historical perspective. Am. J. Psychiatry 2010, 167(2):134-142.
14. Kirkbride J.B., Boydell J., Ploubidis G.B., Morgan C., Dazzan P., McKenzie K., Murray R.M., Jones P.B. Testing the association between the incidence of schizophrenia and social capital in an urban area. Psychol. Med. 2008, 38(8):1083-1094.
15. Kirkbride J.B., Errazuriz A., Croudace T.J., Morgan C., Jackson D., Boydell J., Murray R.M., Jones P.B. Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One 2012, 7(3):e31660.
16. Krawiecka M., Goldberg D., Vaughan M. A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr. Scand. 1977, 55(4):299-308.
17. Krishnadas R., Moore B.P., Nayak A., Patel R.R. Relationship of cognitive function in patients with schizophrenia in remission to disability: a cross-sectional study in an Indian sample. Ann. Gen. Psychiatry 2007, 6:19.
18. Leff J., Trieman N. Long-stay patients discharged from psychiatric hospitals. Social and clinical outcomes after five years in the community. The TAPS Project 46. Br. J. Psychiatry 2000, 176:217-223.
19. Leucht S., Heres S., Kissling W., Davis J.M. Evidence-based pharmacotherapy of schizophrenia. Int. J. Neuropsychopharmacol. 2011, 14(02):269-284.
20. Lynch D., Laws K.R., McKenna P.J. Cognitive behavioural therapy for major psychiatric disorder: does it really work?. A meta-analytical review of well-controlled trials. Psychol. Med. 2010, 40(1):9-24.
21. Manchanda R., Saupe R., Hirsch S.R. Comparison between the Brief Psychiatric Rating Scale and the Manchester Scale for the rating of schizophrenic symptoms. Acta Psychiatr. Scand. 1986, 74(6):563-568.
22. Marcelis M., Navarro-Mateu F., Murray R., Selten J.P., Van Os J. Urbanization and psychosis: a study of 1942-1978 birth cohorts in The Netherlands. Psychol. Med. 1998, 28(4):871-879.
23. McCreadie R.G. The Nithsdale schizophrenia survey: I. Psychiatric and social handicaps. Br. J. Psychiatry 1982, 140:582-586.
24. McCreadie R.G. Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. Br. J. Psychiatry 2002, 181:321-325.
25. McCreadie R.G., Barron E.T. The Nithsdale schizophrenia survey. IV. Social adjustment by self-report. Br. J. Psychiatry 1984, 144:547-550.
26. McCreadie R.G., Barron E.T., Winslow G.S. The Nithsdale schizophrenia survey: II. Abnormal movements. Br. J. Psychiatry 1982, 140:587-590.
27. McCreadie R.G., Crorie J., Barron E.T., Winslow G.S. The Nithsdale schizophrenia survey: III. Handedness and tardive dyskinesia. Br. J. Psychiatry 1982, 140:591-594.
28. McCreadie R.G., Thara R., Kamath S., Padmavathy R., Latha S., Mathrubootham N., Menon M.S. Abnormal movements in never-medicated Indian patients with schizophrenia. Br. J. Psychiatry 1996, 168(2):221-226.
29. McCreadie R.G., Leese M., Tilak-Singh D., Loftus L., MacEwan T., Thornicroft G. Nithsdale, Nunhead and Norwood: similarities and differences in prevalence of schizophrenia and utilisation of services in rural and urban areas. Br. J. Psychiatry 1997, 170:31-36.
30. McGuffin P., Farmer A., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. development and reliability of the OPCRIT system. Arch. Gen. Psychiatry 1991, 48(8):764-770.
31. McKenna P.J. Schizophrenia and Related Syndromes 2007, Routledge, London. 2nd ed.
32. NICE Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care 2002, National Institute for Clinical Excellence, London.
33. NICE Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary care (update) 2009, National Institute for Clinical Excellence, London.
34. Pappa S., Dazzan P. Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review. Psychol. Med. 2008, 39(07):1065.
35. Potvin S., Sepehry A.A., Stip E. A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychol. Med. 2006, 36(4):431-440.
36. Saha S., Chant D., Welham J., McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005, 2(5):e141.
37. Schooler N.R., Kane J.M. Research diagnoses for tardive dyskinesia. Arch. Gen. Psychiatry 1982, 39(4):486-487.
38. Telfer S., Shivashankar S., Krishnadas R., McCreadie R.G., Kirkpatrick B. Tardive dyskinesia and deficit schizophrenia. Acta Psychiatr. Scand. 2011, 124(5):357-362.
39. Thara R. Twenty-year course of schizophrenia: the Madras Longitudinal Study. Can. J. Psychiatry 2004, 49(8):564-569.
40. Trieman N., Leff J. Long-term outcome of long-stay psychiatric in-patients considered unsuitable to live in the community. TAPS Project 44. Br. J. Psychiatry 2002, 181:428-432.
41. Wakefield S., Rowlett L. Unemployment in Scotland - October 1999 1999, Scotland, Parliament, Information Centre.
42. Weissman M.M., Bothwell S. Assessment of social adjustment by patient self-report. Arch. Gen. Psychiatry 1976, 33(9):1111-1115.
43. WHO The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines 1992, World Health Organization, Geneva, (Great Britain).
44. Wojcik J.D., Gelenberg A.J., LaBrie R.A., Mieske M. Prevalence of tardive dyskinesia in an outpatient population. Compr. Psychiatry 1980, 21(5):370-380.
45. Wykes T., Steel C., Everitt B., Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr. Bull. 2007, 34(3):523-537.